The largest psychiatric meta-analysis to date 80 randomized controlled trials, over 107,000 patients also found significant improvements in restrained eating and emotional eating with GLP-1 medications compared to placebo ( Pierret et al., JAMA Psychiatry, 2025 )
Dipeptidyl peptidase-4 (DPP-4) inhibitors, also known as gliptins, are used in the management of type 2 diabetes
One unit of GR was defined as the amount of enzyme required to reduce 1 mol of NADPH with GSSG per minute
sex, diet and treatment interaction: F( 1,54 ) = 3.844, R 2 = 0.051, p = 0.002), but not in WD-fed females ( p = 0.781)
Subject demographics (for example: age, sex, self-identified race), lab values (for example: HbA1c, BMI, liver enzymes), and some medication information (GLP-1 M, other drugs used to treat T2D, and NSAIDs) and presence or absence of diabetes-associated complications (for example: chronic kidney disease, cardiovascular disease) were extracted as prediction features